New tool for uterine sampling to detect gynecological cancers
Official title: DOvEEgene Fleur: New Uterine Sampling Tool
Run by McGill University · NCT04258449 · Data updated 2026-11-12
This study is testing a new tool to see if it can help find signs of gynecological cancers in women who are having surgery for tumors by looking for cancer DNA in samples taken from the uterus.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 40 (estimated) |
| Sponsor | McGill University Academic / other |
| Locations | 1 site (Montreal, Quebec) |
| Status | Recruiting |
| Started | December 11, 2020 |
| Main results expected | October 1, 2026 |
| Study ends | October 1, 2026 |
| Registry record updated | September 26, 2025 |
| Trial ID | NCT04258449 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women aged 18 and older with suspected or confirmed cancer of the upper genital tract who are scheduled for surgery.
✕Probably not a fit
Patients who have had a prior hysterectomy or are pregnant may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to develop and validate a novel molecular test called DOvEEgene, which focuses on early diagnosis of endometrial, tubal, and ovarian cancers by identifying cancer-specific mutations in pap samples taken from the uterus. The study builds on previous research and seeks to improve patient tolerability during sampling by using a new uterine sampling tool. Participants will include women with suspected or confirmed gynecological diseases who are undergoing surgery for tumor removal. The study will assess the effectiveness of this new tool in detecting cancer DNA amidst a challenging background of benign conditions.
Why it matters
Potential benefit: If successful, this study could lead to earlier and more accurate detection of gynecological cancers, improving patient outcomes.
How similar studies have gone: Previous studies have shown promise in using molecular tests for cancer detection, making this approach a continuation of established research.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Be at least 18 years of age. * Have capacity to understand the study. * Be able to provide informed consent. * If the patient has a recently treated cervical abnormality, she must have had a Pap smear with normal results at least 4 months following treatment by loop electrosurgical excision procedure (LEEP) or cone biopsy. * Have suspected or confirmed cancer of the upper genital tract and be undergoing surgery for said tumor removal. Exclusion Criteria: * Prior hysterectomy. * Be pregnant or possibly pregnant. * Be nursing, as the device contains phthalates (plasticizers) that "have not been fully characterized and there may be concern for reproductive and developmental effects". * Have an infected or inflamed cervix. * Have a confirmed or suspected pelvic infection. * Have a confirmed or suspected vaginal infection. * Have had recent history of uterine perforation. * Patients with recently treated cervical abnormalities must have a Pap smear with normal results at least 4 months following treatment by loop electrosurgical excision procedure (LEEP) or cone biopsy in order to be eligible.
Where it's running
-
Royal Victoria Hospital (Glen Site)
Montreal, Quebec, Canada Recruiting
Study contacts
- Study coordinator: Dr. Lucy Gilbert, MD,MSc,FRCOG
- Email: lucy.gilbert@mcgill.ca
- Phone: (514) 934-1934
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ketone plus protein after workouts to see if it helps keep and build muscle in young men
This study tests whether taking a ketone supplement with protein after resistance exercise helps better retain amino acids and reduce muscle breakdown in young, trained men.
-
Operation Calm: VR nature-based mindfulness for kids facing procedures
A VR nature-guided mindfulness session is being tested to help 6–17 year olds, with parents and clinicians observing, to see if it helps reduce preoperative and procedural anxiety.
-
Weight loss and brain health in adults with obesity
This study tests whether weight loss with semaglutide affects brain health in adults aged 35-55, by comparing people with obesity to lean controls over about 80 weeks.
-
How exercise affects the immune system and brain in chronic low back pain
This trial will test whether a 12-week online exercise program changes immune activity, brain function, and pain for adults with chronic low back pain compared with a waitlist group.
-
Immersive virtual reality to reduce wound‑care pain in long‑term care residents (pilot)
This pilot will try immersive virtual reality headsets during dressing changes to see if VR reduces pain and distress for long‑term care residents with pressure ulcers.
-
Protecting the brain after stroke with multimodal exercise
This test tries a 12-week multimodal exercise program for people within six months of a first stroke to see if it preserves thinking skills and lowers brain markers linked to dementia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.